Navigation Links
Accuray Launches First Study to Compare CyberKnife® SBRT to Surgery and IMRT for Treatment of Early-Stage Prostate Cancer
Date:4/26/2012

SUNNYVALE, Calif., April 26, 2012 /PRNewswire/ -- Accuray Incorporated (Nasdaq: ARAY), the premier radiation oncology company, announced today the launch of the Prostate Advances in Comparative Evidence (PACE) Study, an international, multi-center, randomized study to compare CyberKnife® Stereotactic Body Radiation Therapy (SBRT), da Vinci assisted and manual laparoscopic surgery and conventionally fractionated intensity modulated radiation therapy (IMRT), for the treatment of localized prostate cancer. The PACE Study aims to build upon the strong foundation of published evidence for CyberKnife prostate SBRT by creating comparative evidence to support its future potential as the gold standard in the treatment of organ confined prostate cancer. This information will enable clinicians and patients to make informed treatment decisions based on the highest level of clinical evidence. 

Currently, there is no clear gold standard for localized prostate cancer treatment. A lack of comparative clinical data has prevented definitive conclusions to be drawn as to which therapy can be considered the preferred treatment for localized prostate cancer. Treatment decisions have often been made based on historical experience, aged comparisons of older treatment techniques or single modality experiences. Physicians and leading industry groups, including The Agency for Healthcare Quality and Research (AHRQ) and the Medicare Evidence Development and Coverage Advisory Committee (MEDCAC), have called for a randomized study comparing the most popular treatment options to bring clarity to the treatment landscape.

The PACE Study was created by a consortium of leading academic centers in Europe—including Royal Marsden NHS Foundation Trust in the UK, Center Oscar Lambret in France
'/>"/>

SOURCE Accuray Incorporated
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Accuray Incorporated to Report Financial Results for First Quarter of Fiscal 2010
2. Accuray Incorporated to Present at 20th Annual Oppenheimer Healthcare Conference
3. Accuray Ranked 155th Fastest Growing Company in North America on Deloittes 2009 Technology Fast 500(TM)
4. Accuray Announces Regionalized Management Strategy for Americas
5. Accurays Treatment Planning Service Active at 20 Percent of U.S. CyberKnife Centers
6. Accuray Introduces the CyberKnife(R) VSI(TM) System
7. Accuray Announces Results for Second Quarter Fiscal 2010
8. Accuray Incorporated to Report Financial Results for Second Quarter of Fiscal 2010
9. Accuray Hires General Manager for Japan
10. Accuray Incorporated to Present at 28th Annual J. P. Morgan Healthcare Conference
11. Accuray Incorporated to Present at Piper Jaffray Healthcare Conference and J. P. Morgan Small/Mid Cap Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/31/2015)... Calif. , Aug. 31, 2015  Regulatory ... and government, where regulations are often strict and ... is driving a demand for professionals who have ... these regulations across a product lifecycle and demonstrate ... The University of California, Irvine Extension , ...
(Date:8/31/2015)... , Aug. 31, 2015 Regen BioPharma, ... development of a novel means of delivering its ... RGBP-248, to liver tumors utilizing a clinically approved ... overcomes previous hurdles with gene silencing therapeutics in ... delivered throughout the whole body.  By utilizing a ...
(Date:8/31/2015)... MOUNTAIN VIEW, Calif. , Aug. 31, ... EURONEXT: SAN) and the life sciences team at Google ... and outcomes for people with type 1 and type ... and devices with Google,s expertise in analytics, miniaturized electronics ... how to improve diabetes care by developing new tools ...
Breaking Medicine Technology:UC Irvine Extension Launches New Regulatory Affairs and Compliance Certificate Program 2UC Irvine Extension Launches New Regulatory Affairs and Compliance Certificate Program 3Regen BioPharma, Inc. Develops BORIS Gene Silencing Based Treatment for Unresectable Liver Cancer 2Regen BioPharma, Inc. Develops BORIS Gene Silencing Based Treatment for Unresectable Liver Cancer 3Sanofi to Collaborate with Google Life Sciences to Improve Diabetes Health Outcomes 2Sanofi to Collaborate with Google Life Sciences to Improve Diabetes Health Outcomes 3Sanofi to Collaborate with Google Life Sciences to Improve Diabetes Health Outcomes 4Sanofi to Collaborate with Google Life Sciences to Improve Diabetes Health Outcomes 5Sanofi to Collaborate with Google Life Sciences to Improve Diabetes Health Outcomes 6
(Date:8/31/2015)... ... August 31, 2015 , ... ... was formed in 2008, the result of a merger of five of the ... working cooperatively, they could provide more cost-effective and higher quality care than they ...
(Date:8/31/2015)... ... ... NJ Top Docs Presents, Dr. Michael Betsy! Dr. Betsy has been reviewed and approved ... Betsy graduated from Don Bosco Prep in 1990 and was Class Salutatorian. He earned ... in his senior year. He was inducted into the National Honor Society as a ...
(Date:8/31/2015)... TN (PRWEB) , ... August 31, 2015 , ... ... how it may be prevented during Amblyopia Awareness Month. Only a comprehensive eye examination ... the most common cause of visual impairment among children, affecting approximately 2 to 3 ...
(Date:8/31/2015)... (PRWEB) , ... August 31, 2015 , ... ... and digital marketing communications company announced today that it has officially launched a ... President, the new website and brand refresh are more closely aligned with the ...
(Date:8/31/2015)... , ... August 31, 2015 , ... Three Bakers Gluten ... and retailers with even more relevant and easy-to-find information on their offering of gluten-free ... website has always been an important way for us to share information about our ...
Breaking Medicine News(10 mins):Health News:NJ Top Docs Presents, Garden State Urology! 2Health News:NJ Top Docs Presents, Dr. Michael Betsy! 2Health News:NJ Top Docs Presents, Dr. Michael Betsy! 3Health News:Renowned Eye Surgeon Dr. Stewart Shofner Shares Information about the Causes of Lazy Eye During Amblyopia Awareness Month 2Health News:Renowned Eye Surgeon Dr. Stewart Shofner Shares Information about the Causes of Lazy Eye During Amblyopia Awareness Month 3Health News:Diablo Publications Launches New Company Website 2Health News:Diablo Publications Launches New Company Website 3Health News:Three Bakers Gluten Free Bakery Announces Launch of New Website 2
... for the state,s elderly, disabled, and ... ... plans to cut hundreds of millions of dollars from Medicaid,programs for the ... all Floridians, the leaders of Florida,s safety net,hospitals warned today., Besides ...
... 10, 2008 The American Pain Society (APS), www.ampainsoc.org ... Clinical Centers of Excellence in Pain Management Awards recognizing ... pain programs were recognized. They are: , ... Center, Lebanon, NH , Pediatric ...
... 10, 2008 Data presented at this weeks 28th ... for Heart and Lung Transplantation (ISHLT) suggest the potential ... the need for biopsies and personalize transplant patient care. ... called biomarkers could offer transplant patients personalized care and ...
... recommended by David Spiegel of Faculty of 1000 Medicine ... care management and survival rates in older patients. He ... the effects of treatment of depression on survival in ... mind-body interactions and professor of psychiatry and behavioural sciences ...
... you are getting forgetful as you get older, then a ... Medical School in the South West of England may have ... foods, such as blueberries, are effective at reversing age-related deficits ... in the science journal Free Radical Biology and Medicine. ...
... Heralds Ends of Program Focused on ... Locations Offering Discounts for Healthcare Workers From ... April 11 - 14, ... Hewitt Tax Service(R) in the days,before the tax filing deadline are likely to ...
Cached Medicine News:Health News:Massive Medicaid Cuts Will Impact All Floridians, Safety Net Hospital Leaders Warn 2Health News:Massive Medicaid Cuts Will Impact All Floridians, Safety Net Hospital Leaders Warn 3Health News:American Pain Society announces recipients of Clinical Centers of Excellence Awards 2Health News:American Pain Society announces recipients of Clinical Centers of Excellence Awards 3Health News:Biomarkers may reduce need for biopsies 2Health News:Biomarkers may reduce need for biopsies 3Health News:Getting forgetful? Then blueberries may hold the key 2Health News:Jackson Hewitt(R) Celebrates Healthcare Workers With Occupation-Based Tax Savings 2Health News:Jackson Hewitt(R) Celebrates Healthcare Workers With Occupation-Based Tax Savings 3
6.3X Zoom Ratio - Boasting magnifications from 0.8X to 5X, the twin zooming objective optical system developed exclusively by Nikon provides a zoom ratio of 6.3:1. Clickstops at 1X intervals allow ob...
... With a zoom ratio of ... 0.75X to 11.25X, and the ... intervals from 1X to 11X, ... Magnifications of 3.75X to 540X ...
Inquire...
Fluar objectives have been designed especially for qualitative and quantitative analyses of ion movements and for particularly critical fluorescence methods (e.g. chromosome studies in human and cyto...
Medicine Products: